Company: THC
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0000070318-25-000046
Chunk: 61

Company: TENET HEALTHCARE CORP
Filing Date: 2025-10-28
Form: 10-Q
Item: Part I, Item 1
Chunk 61
---
, could obligate us to purchase some or all of the noncontrolling interests related to our consolidated subsidiaries. The noncontrolling interests subject to these provisions, and the income available to those interests, are not included as part of our equity and are presented as redeemable noncontrolling interests in the accompanying Condensed Consolidated Balance Sheets at September 30, 2025 and December 31, 2024.The following table presents the changes in redeemable noncontrolling interests in equity of consolidated subsidiaries: Nine Months Ended September 30, 20252024Balances at beginning of period $2,727 $2,391 Net income381 336 Distributions paid to noncontrolling interests(311)(269)Accretion of redeemable noncontrolling interests— 5 Purchases and sales of businesses and noncontrolling interests, net120 186 Balances at end of period $2,917 $2,649 The divestiture of the AL Hospitals during the three months ended September 30, 2024 resulted in a decrease of $175 million in our redeemable noncontrolling interest balance during the same period.The following tables present the composition by segment of our redeemable noncontrolling interests balances, as well as our net income available to redeemable noncontrolling interests: September 30, 2025December 31, 2024Hospital Operations$879 $800 Ambulatory Care2,038 1,927 Redeemable noncontrolling interests$2,917 $2,727  Nine Months Ended September 30, 20252024Hospital Operations$82 $74 Ambulatory Care299 262 Net income available to redeemable noncontrolling interests$381 $336 In June 2022, we entered into a share purchase agreement to acquire the 5% ownership interest then-held by Baylor University Medical Center in USPI for $406 million. Under the share purchase agreement, we were obligated to make non‑interest-bearing monthly payments through June 2025. We repaid the outstanding balance under the share purchase agreement in full during the three months ended June 30, 2025. At December 31, 2024, the remaining obligation under the share purchase agreement of $68 million was included in other current liabilities in the accompanying Condensed Consolidated Balance Sheet.

17

NOTE 13. INCOME TAXES

A reconciliation between the amount of reported income